Jonathan Guarino
Director of Finance/CFO bei SOLIGENIX, INC.
Vermögen: 440 $ am 31.03.2024
Profil
Jonathan L.
Guarino is currently the Chief Financial Officer, Secretary & Senior VP at Soligenix, Inc. Prior to this, he worked as the Controller at Hepion Pharmaceuticals, Inc. from 2016 to 2019.
He also served as the Senior Manager-Technical Accounting at Labcorp Drug Development, Inc. from 2014 to 2015 and as the Controller at Suite-K Value Added Services LLC from 2015 to 2016.
Mr. Guarino completed his undergraduate degree at Montclair State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SOLIGENIX, INC.
0,01% | 08.03.2024 | 734 ( 0,01% ) | 440 $ | 31.03.2024 |
Aktive Positionen von Jonathan Guarino
| Unternehmen | Position | Beginn |
|---|---|---|
| SOLIGENIX, INC. | Director of Finance/CFO | 11.09.2019 |
Ehemalige bekannte Positionen von Jonathan Guarino
| Unternehmen | Position | Ende |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.07.2019 |
| Suite-K Value Added Services LLC | Comptroller/Controller/Auditor | 01.09.2016 |
| COVANCE INC. | Comptroller/Controller/Auditor | 01.05.2015 |
Ausbildung von Jonathan Guarino
| Montclair State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
| Suite-K Value Added Services LLC |
